Vijaya Diagnostic Centre Limited (VIJAYA.BO)
INR 1059.65
(-1.01%)
INR 1059.65
(-1.01%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3.22 Billion INR | 5.24% |
| 2022 | 3.06 Billion INR | 25.77% |
| 2021 | 2.43 Billion INR | 34.02% |
| 2020 | 1.82 Billion INR | -12.55% |
| 2019 | 2.08 Billion INR | 4.36% |
| 2018 | 1.99 Billion INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | -6.59 Billion INR | -304.41% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 3.22 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 3.26 Billion INR | 0.0% |
| 2023 FY | 3.22 Billion INR | 5.24% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 3.06 Billion INR | 25.77% |
| 2022 Q4 | 3.06 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 2.97 Billion INR | 0.0% |
| 2021 Q2 | 2.26 Billion INR | 6.95% |
| 2021 Q4 | 2.43 Billion INR | 0.0% |
| 2021 FY | 2.43 Billion INR | 34.02% |
| 2021 Q1 | 2.11 Billion INR | 16.3% |
| 2021 Q3 | - INR | -100.0% |
| 2020 FY | 1.82 Billion INR | -12.55% |
| 2020 Q4 | 1.82 Billion INR | 0.0% |
| 2020 Q1 | - INR | 0.0% |
| 2019 FY | 2.08 Billion INR | 4.36% |
| 2018 FY | 1.99 Billion INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Krsnaa Diagnostics Limited | 3.62 Billion INR | 10.845% |
| Dr. Lal PathLabs Limited | 5.7 Billion INR | 43.421% |
| Metropolis Healthcare Limited | 4.55 Billion INR | 29.168% |
| Thyrocare Technologies Limited | 1.16 Billion INR | -177.713% |
| Vimta Labs Limited | 803.54 Million INR | -301.774% |